Vifor, ChemoCentryx expand kidney health alliance to include renal diseases January 3, 2017 CenterWatch Staff
Cempra receives complete response letter from FDA for solithromycin NDAs January 3, 2017 CenterWatch Staff
Early-phase trial demonstrates shrinkage in pediatric neural tumors January 3, 2017 CenterWatch Staff
Capnia, Essentialis merge to create rare disease therapeutics company January 2, 2017 CenterWatch Staff